HEALTH — Nightingale Health Oyj Share News
0.000.00%
Last trade - 00:00- €70.45m
- €37.75m
- €5.50m
Brief: Nightingale Health And Innoquest Diagnostics Enter Into Collaboration Agreement
Brief: Nightingale Health H2 Revenue Up At EUR 1.94 Mln
Brief: Nightingale Health Receives Three New Patents
Brief: Nightingale Health To Provide Blood Sample Analysis Service For Large U.S. Healthcare System
Brief: Terveystalo Adopts Nightingale Health's Blood Analysis Technology
Brief: Nightingale Health Updates On Business Targets For 2022-2023
Brief: Nightingale Health, Terveystalo Sign LOI To Expand Partnership
Brief: Nightingale Receives Patent Approvals For Health Risk Detection Platform
Brief: Nightingale Health H1 EBITDA Loss Widens To EUR 5.5 Mln
Brief: Nightingale Health To Open Laboratory In UK In 2023
Brief: Nightingale Updates On Business Targets For FY 2021-2022
Brief: Nightingale Health H2 EBITDA Loss Widens To EUR 3.25 Million
Brief: Nightingale Health Acquires Negen, Launches International Centre Of Excellence For Genomic Data Analysis
Brief: Nightingale Expands Its Japan Laboratory
Brief: Nightingale Starts Pilot Project In Tokyo
Brief: Nightingale Health Appoints Tuukka Paavola As CFO
Brief: Nightingale And Biobank Japan To Realise Personalised Medicine And Preventative Health In Japan
Brief: Nightingale Enters Into Partnership With Finnish Yliopiston Apteekki
Brief: Nightingale Considered To Comply With Requirements For Manufacturer Of Medical Device